New Drug Exclusivity Not Impacted By Impurities In Compound, Court Finds In Loss For Sandoz

 
• By Brenda Sandburg
  
FDA approval
Appeals court backs FDA award of exclusivity for multiple sclerosis drug • Source: Shutterstock

More from US FDA

More from Agency Leadership